載入...
PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
Herein, we report the use of a theranostic nanocarrier (Folate-HBPE(CT20p)) to deliver a therapeutic peptide to prostate cancer tumors that express PSMA (folate hydrolase 1). The therapeutic peptide (CT20p) targets and inhibits the chaperonin-containing TCP-1 (CCT) protein-folding complex, is select...
Na minha lista:
| 發表在: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Ivyspring International Publisher
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5525751/ https://ncbi.nlm.nih.gov/pubmed/28744329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.18879 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|